NOVN Stock: Novan surges on patent Nitric Oxide Releasing Compositions

Jay Lorrence
January 21, 2021
Biotech Stocks, Featured

Shares of Novan (NOVN) stock has surged 10% on the company getting granted patent on Nitric Oxide Releasing Compositions in Europe.

This most likely is connecting to their inhalent drug for COVID-19.

Jay Lorrence

Investor of 12 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.

Articles: 230

👆 Sign up now and don’t miss these hot stock picks!

Jay Lorrence